Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: The Impact of Hafnia Alvei on Weight Loss and Glycaemic Control After Bariatric Surgery [NA]

View source ↗

Summary

An active, not-recruiting clinical trial assessing whether Hafnia alvei supplementation influences weight loss and glycemic control after bariatric surgery in o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hafnia alvei (Hafnia alvei)

Snippet

Sponsor: Universidade Nova de Lisboa | Conditions: Obesity, Type 2 Diabetes | NA | Status: ACTIVE_NOT_RECRUITING